SXSW 2024
The COVID-19 Emergency is Over. Now What?
Description:
The state of emergency for COVID-19 is over, and timely access to info & care is less universal. We’ll explore learnings from the pandemic, & how to apply these insights to reduce gaps in care for COVID-19 & other serious respiratory conditions. We’ll discuss how AI & online tools are shaping a new era of patient engagement, how digital platforms can increase access to testing, treatments & vaccines, & the ongoing clinical focus on long-COVID. Learn how digital health, life sciences and health systems are working together to transform the industry & help patients overcome barriers to care.
Related Media
Other Resources / Information
Takeaways
- The National Institutes of Health is investing billions to study cognitive/neurologic and biologic effects of long COVID and potential treatments.
- The end of the state of emergency requires a more intentional effort to care for high risk COVID-19 and long COVID patients.
- Populations impacted by political, socioeconomic and cultural barriers can benefit from free digital technologies and research opportunities.
Speakers
- JoyL Silva, Global COVID Antiviral Franchise Team Lead, Pfizer
- Nirav Shah, MD, MPH, Director of Infectious Disease Research, Outcomes Research and Medical Director of Quality Innovation and Clinical Practice Analytics, NorthShore – Edward-Elmhurst Health
- Claire Novorol, Co-Founder and Chief Medical Officer, Ada Health
Organizer
Shira Derasmo, Founder, Cuttlefish Communications
SXSW reserves the right to restrict access to or availability of comments related to PanelPicker proposals that it considers objectionable.
Add Comments